Sadi Loai1, Inga E. Haedicke2,3, Zahra Mirzaei1, Craig Simmons1,4, Xiao-an Zhang2,3, and Hai-Ling Margaret Cheng1,5
1Institute of Biomaterials & Biomedical Engineering, University of Toronto, Toronto, ON, Canada, 2Department of Physical and Environmental Sciences, University of Toronto Scarborough, Toronto, ON, Canada, 3Chemistry, University of Toronto, Toronto, ON, Canada, 4Mechanical and Industrial Engineering, University of Toronto, Toronto, ON, Canada, 5The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, University of Toronto, Toronto, ON, Canada
Synopsis
Embryonic stem (ES) cells
offer promise for regenerating a variety of tissue types. One difficult aspect
to advancing this technology is determining the fate of these cells once they
are introduced inside the body. MRI can play an important role for non-invasive
monitoring in patients, but conventional methods based on iron oxides have limited
specificity. In this study, a novel, highly efficient T1 agent is investigated
for labelling mouse ES cells. A drastic decrease in T1 was obtained and
sustained for at least 24 hours. Viability and proliferation were unaffected,
and labelled ES cells were differentiated into beating cardiomyocytes.Target Audience
stem cell biologist,
tissue engineer
Purpose
Embryonic stem (ES)
cells have the unique potential of developing into all the different cell types
in our body and offer exciting new potential in the field of regenerative
medicine. Non-invasive cell tracking of ES cells can enable us to determine if
they survive in vivo, migrate to the desired location, and engraft properly.
Conventional cell tracking on MRI usually employs iron oxides (SPIO) that
generate negative contrast, an approach with limited specificity, as blood
clots and vessels also appear dark, as do macrophages that will ingest the SPIO
should the labelled cells die. In this study, we investigate the use of a
highly efficient, cell permeable, and cell retentive T1 contrast agent, MnAMP
1, for labelling mouse ES cells.
Methods
R1/E mouse ES cells produced from
the Nagy lab (Nagy, Rossant and Abramow-Newerly) were cultured on a layer of
mouse embryonic fibroblasts until they reached 70% confluency. The stem cells were
cultured on the fibroblasts for the first two passages and then transferred to
a feeder-free flask with a layer of 0.1% gelatin. Cells were labelled with 0.1
mM of MnAMP for various labelling intervals and kept in contrast-free medium
for different retention periods. Cell
pellets were prepared in glass vials and imaged on a 3.0T scanner (Achieva 3.0
T TX, Philips Medical Systems) using a 32-channel head coil. T1 mapping was
performed using inversion recovery turbo spin echo: TR = 3000 ms, TE = 18.5 ms,
5 cm field-of-view, 3 mm slices, 0.5 x 0.5 mm in-plane resolution, and TI =
[50, 100, 250, 500, 750, 1000, 1250, 1500, 2000 and 2500] ms. Atomic absorption spectroscopy was used to
assess intracellular manganese content. Viability
and proliferation of labelled samples was assessed. The ability of ES cells to
differentiate into cardiomyocytes was determined using the hanging drop method
2.
Results
Viability and
proliferation assays confirmed no adverse effect from cell labelling with MnAMP
at 0.1 mM. Viability was 84.1% for 24-hour labelled ES cells compared to 86.7%
for control; proliferation rates remained constant. Fig. 1 shows a T1-weighted image of labelled
cell pellets prepared with different labelling intervals and retention periods.
Fig. 2 compares changes in T1 across different labelling and retention
intervals. Fig. 3 demonstrates that labelling did not affect the ES cells’
ability to differentiate into cardiomyocytes; spontaneous contractions were
observed in both control cells and labelled cardiomyocytes.
Discussion
MnAMP is a highly
efficient T1 contrast agent for labelling mouse ES cells. A significant reduction in T1 was achieved
from a 2-hour incubation interval, and the significant change in contrast was
maintained 24 hours post-labelling. Viability and proliferation were
unaffected. Most importantly, the capacity of the ES cells to differentiate
into beating cardiomyocytes was preserved.
Conclusion
We have presented a
promising new method for sensitive MRI tracking of embryonic stem cells to
study cellular therapies and tissue engineering and regeneration strategies.
Acknowledgements
Funding from the Heart & Stroke Foundation of Canada, the University of Toronto's Director Kickstart Award, and the Natural Sciences and Engineering Research Council of Canada.References
1. Zhang XA, Haedicke I, Cheng HL. MRI contrast agents for cell labeling, International PCT #PCT/CA2014/050969; US PCT patent
application 62/034,344.
2. Wang X, Yang P. In vitro differentiation of mouse embryonic stem (mES)
cells using the hanging drop method. J Vis Exp 2008 (17).